Armune BioScience
Armune BioScience: Blood Tests to Aid in Risk Assessment for Prostate, Breast, & Lung Cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD27—41m (Dealroom.co estimates Sep 2016.)
Kalamazoo Michigan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Early VC | ||
| N/A | $400k | Debt | |
$250k | Debt | ||
| N/A | $1.4m | Debt | |
| N/A | $4.0m | Series A | |
| N/A | $5.0m | Series A | |
N/A | Acquisition | ||
| Total Funding | CAD12.3m | ||
Related Content
Recent News about Armune BioScience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.